Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 27

References for PMC Articles for PubMed (Select 18381641)

1.

Characterization of MYC translocations in multiple myeloma cell lines.

Dib A, Gabrea A, Glebov OK, Bergsagel PL, Kuehl WM.

J Natl Cancer Inst Monogr. 2008;(39):25-31. doi: 10.1093/jncimonographs/lgn011.

2.

Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ, Van Wier S, Tiedemann R, Shi CX, Sebag M, Braggio E, Henry T, Zhu YX, Fogle H, Price-Troska T, Ahmann G, Mancini C, Brents LA, Kumar S, Greipp P, Dispenzieri A, Bryant B, Mulligan G, Bruhn L, Barrett M, Valdez R, Trent J, Stewart AK, Carpten J, Bergsagel PL.

Cancer Cell. 2007 Aug;12(2):131-44.

3.

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.

Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F, Lenz G, Hanamura I, Wright G, Xiao W, Dave S, Hurt EM, Tan B, Zhao H, Stephens O, Santra M, Williams DR, Dang L, Barlogie B, Shaughnessy JD Jr, Kuehl WM, Staudt LM.

Cancer Cell. 2007 Aug;12(2):115-30.

4.

Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling.

Chng WJ, Kumar S, Vanwier S, Ahmann G, Price-Troska T, Henderson K, Chung TH, Kim S, Mulligan G, Bryant B, Carpten J, Gertz M, Rajkumar SV, Lacy M, Dispenzieri A, Kyle R, Greipp P, Bergsagel PL, Fonseca R.

Cancer Res. 2007 Apr 1;67(7):2982-9.

5.

Analysis of genetic abnormalities provides insights into genetic evolution of hyperdiploid myeloma.

Chng WJ, Ketterling RP, Fonseca R.

Genes Chromosomes Cancer. 2006 Dec;45(12):1111-20.

PMID:
16955468
6.

Distinguishing primary and secondary translocations in multiple myeloma.

Gabrea A, Leif Bergsagel P, Michael Kuehl W.

DNA Repair (Amst). 2006 Sep 8;5(9-10):1225-33. Epub 2006 Jul 10. Review.

PMID:
16829212
7.

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma.

Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J Jr.

Blood. 2005 Jul 1;106(1):296-303. Epub 2005 Mar 8.

8.

Genetics and cytogenetics of multiple myeloma: a workshop report.

Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M, Davies FE, Drach J, Greipp PR, Kirsch IR, Kuehl WM, Hernandez JM, Minvielle S, Pilarski LM, Shaughnessy JD Jr, Stewart AK, Avet-Loiseau H.

Cancer Res. 2004 Feb 15;64(4):1546-58.

9.

Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.

Smadja NV, Leroux D, Soulier J, Dumont S, Arnould C, Taviaux S, Taillemite JL, Bastard C.

Genes Chromosomes Cancer. 2003 Nov;38(3):234-9.

PMID:
14506697
10.

The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.

Fonseca R, Debes-Marun CS, Picken EB, Dewald GW, Bryant SC, Winkler JM, Blood E, Oken MM, Santana-Dávila R, González-Paz N, Kyle RA, Gertz MA, Dispenzieri A, Lacy MQ, Greipp PR.

Blood. 2003 Oct 1;102(7):2562-7. Epub 2003 Jun 12.

11.

Clinical and biologic implications of recurrent genomic aberrations in myeloma.

Fonseca R, Blood E, Rue M, Harrington D, Oken MM, Kyle RA, Dewald GW, Van Ness B, Van Wier SA, Henderson KJ, Bailey RJ, Greipp PR.

Blood. 2003 Jun 1;101(11):4569-75. Epub 2003 Feb 6.

12.

Genomic abnormalities in monoclonal gammopathy of undetermined significance.

Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA, Kyle RA, Gertz MA, Greipp PR, Dewald GW.

Blood. 2002 Aug 15;100(4):1417-24.

13.

Multiple myeloma: evolving genetic events and host interactions.

Kuehl WM, Bergsagel PL.

Nat Rev Cancer. 2002 Mar;2(3):175-87. Review.

PMID:
11990854
14.

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.

Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Rapp MJ, Harousseau JL, Minvielle S, Bataille R; Intergroupe Francophone du Myélome.

Blood. 2002 Mar 15;99(6):2185-91.

15.

Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.

Avet-Loiseau H, Gerson F, Magrangeas F, Minvielle S, Harousseau JL, Bataille R; Intergroupe Francophone du Myélome.

Blood. 2001 Nov 15;98(10):3082-6.

16.

Chromosome translocations in multiple myeloma.

Bergsagel PL, Kuehl WM.

Oncogene. 2001 Sep 10;20(40):5611-22. Review.

17.

Hypodiploidy is a major prognostic factor in multiple myeloma.

Smadja NV, Bastard C, Brigaudeau C, Leroux D, Fruchart C; Groupe Français de Cytogénétique Hématologique.

Blood. 2001 Oct 1;98(7):2229-38.

18.

Cyclin D3 at 6p21 is dysregulated by recurrent chromosomal translocations to immunoglobulin loci in multiple myeloma.

Shaughnessy J Jr, Gabrea A, Qi Y, Brents L, Zhan F, Tian E, Sawyer J, Barlogie B, Bergsagel PL, Kuehl M.

Blood. 2001 Jul 1;98(1):217-23.

19.

Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.

Sawyer JR, Lukacs JL, Thomas EL, Swanson CM, Goosen LS, Sammartino G, Gilliland JC, Munshi NC, Tricot G, Shaughnessy JD Jr, Barlogie B.

Br J Haematol. 2001 Jan;112(1):167-74.

PMID:
11167798
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk